MiniMed Group, Inc. (MMED)
NASDAQ: MMED · Real-Time Price · USD
12.94
+0.02 (0.15%)
At close: Apr 28, 2026, 4:00 PM EDT
13.16
+0.22 (1.70%)
After-hours: Apr 28, 2026, 7:39 PM EDT

MiniMed Group Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023
Period Ending
Jan '26 Apr '25 Apr '24 Apr '23
Revenue
2,9892,7152,4692,245
Revenue Growth (YoY)
21.06%9.96%9.98%-
Cost of Revenue
1,2931,1871,031929
Gross Profit
1,6961,5281,4381,316
Selling, General & Admin
1,1601,0801,057960
Research & Development
456436437429
Other Operating Expenses
9-811-12
Operating Expenses
1,6251,5081,5051,377
Operating Income
7120-67-61
Other Non Operating Income (Expenses)
--1-1-6
EBT Excluding Unusual Items
7119-68-67
Merger & Restructuring Charges
-20--1-8
Legal Settlements
-176-165--
Pretax Income
-243-146-69-75
Income Tax Expense
56523816
Earnings From Continuing Operations
-299-198-107-91
Minority Interest in Earnings
-21-15-5-5
Net Income
-320-213-112-96
Net Income to Common
-320-213-112-96
Free Cash Flow
-168-53-107-173
Gross Margin
56.74%56.28%58.24%58.62%
Operating Margin
2.38%0.74%-2.71%-2.72%
Profit Margin
-10.71%-7.85%-4.54%-4.28%
Free Cash Flow Margin
-5.62%-1.95%-4.33%-7.71%
EBITDA
2261636254
EBITDA Margin
7.56%6.00%2.51%2.40%
D&A For EBITDA
155143129115
EBIT
7120-67-61
EBIT Margin
2.38%0.74%-2.71%-2.72%
Source: S&P Capital IQ. Standard template. Financial Sources.